---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-138138"
form_type: "8-K"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2025-06-10T23:59:59+00:00"
generated_at: "2026-05-19T15:42:53.220521+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Recursion cuts workforce ~20%, extends cash runway to Q4 2027; $11M severance charges

## Summary
- Workforce reduction of ~20%; expects ~$11M in severance and related costs in 2025.
- Cash runway now projected into Q4 2027; cash burn guidance <$450M in 2025, <$390M in 2026.
- Expects Q2 2025 cash above $500M; includes $28M R&D tax credit and >$100M potential milestone inflows by end 2026.
- Reduction part of streamlined operating strategy and post-integration transitions.

## SEC filing metadata
- accession: 0001193125-25-138138
- form_type: 8-K
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2025-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.05, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000119312525138138/0001193125-25-138138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000119312525138138/d80288d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-138138
- JSON: https://secwatch.observer/filing/0001193125-25-138138.json
- Plain text: https://secwatch.observer/filing/0001193125-25-138138.txt

## Key facts
- Restructurings & Charges
  RECURSION PHARMACEUTICALS, INC. announced a restructuring with charges of approximately $11 million (approximately 20%).
  - Type: restructuring
  - Charge: approximately $11 million
  - Headcount: approximately 20%
  source text: into the fourth quarter of 2027. These changes are expected to result in a workforce reduction of approximately 20%. The Company estimates that it will incur approximately $11 million in charges in connection with the workforce reduction, consisting of severance payments, employee benefits, and related costs, substantially all of which the Company expects to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1601830/000119312525138138/0001193125-25-138138-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.